
Katsuaki Maehara/X
Oct 11, 2024, 15:17
Katsuaki Maehara: Summary of Major Clinical Trials of ICI’s in Early Stage NSCLC
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:
”Summary of Major Clinical Trials of Immune Checkpoint Inhibitors (ICI’s) in Early Stage NSCLC. As of September 2024.
Study design.
Key Clinical Data.”
Source: Katsuaki Maehara/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 06:33
Sep 7, 2025, 06:07
Sep 7, 2025, 06:06
Sep 7, 2025, 05:55
Sep 7, 2025, 05:46
Sep 7, 2025, 05:24
Sep 7, 2025, 05:18
Sep 7, 2025, 05:14
Sep 7, 2025, 05:09
Sep 7, 2025, 05:05
Sep 7, 2025, 04:54